ASSESSMENT OF MEMBRANE STABILIZATION, ANTIOXIDANT AND THROMBOLYTIC POTENTIAL OF LUTEIN- AN IN-VITRO STUDY
HTML Full TextASSESSMENT OF MEMBRANE STABILIZATION, ANTIOXIDANT AND THROMBOLYTIC POTENTIAL OF LUTEIN- AN IN-VITRO STUDY
V. Vidya 1, Yogish Somayaji T. 1, S. Pooja 1, Shrikant Patil 2, Ronald Fernandes 3 and A. P. Krishna *2
Central Research Laboratory 1, KS Hegde Medical Academy, Nitte University, Karnataka, India.
Department of Physiology 2, KS Hegde Medical Academy, Nitte University, Karnataka, India.
Department of Biochemistry 3, Nitte Gulabi Shetty Memorial Institute of Pharmaceutical Sciences, Nitte University, Karnataka, India.
ABSTRACT: Lutein; an orange-red colored powder, insoluble in water; is a member of the carotenoid family, a xanthophyll pigment. Lutein was evaluated for its antioxidant property when dissolved in different solvents. Solvents used in the study were chloroform, ethanol, methanol and dimethyl sulfoxide (DMSO). The antioxidant potential of lutein was evaluated by total antioxidant capacity, 2, 2’-diphenyl-1-picrylhydrazyl (DPPH), ferric anion reducing power assay (FRAP), 2,2’-azino-bis-3-ethylbenzthiazoline-6-sulfonic acid (ABTS) radical scavenging, hydroxyl radical scavenging, superoxide radical scavenging and hydrogen peroxide radical scavenging assays. It was also assessed for its antihemolytic and thrombolytic potential. Antioxidant property was compared to that of a standard (gallic acid). The antihemolytic property was assessed by the percentage inhibition of hemolysis in heat induced hemolytic assay and osmotic fragility test. The thrombolytic potential was evaluated by the percentage of clot dissolved by lutein in different solvents. Aspirin and trypsin were used as positive controls for antihemolytic and thrombolytic assays respectively. The results for total antioxidant capacity and FRAP were given in terms of gallic acid equivalents and the others were recorded as percentage radical scavenging activity of lutein. In comparison to gallic acid, the antioxidant property of lutein dissolved in various solvents was not very significant. It however showed antioxidant property in all the solvents and a moderate activity was seen when dissolved in chloroform and methanol compared to the other solvents. It was observed that lutein when dissolved in chloroform has shown to reduce heat induced hemolysis; though no significant difference was observed in hemolysis induced by hypotonic solution when compared to aspirin. The thrombolytic activity of lutein dissolved in ethanol was mild when compared to that of trypsin whereas lutein when dissolved in methanol and DMSO did not exhibit any thrombolytic property
Keywords: |
Antioxidant, Anti-hemolytic, Carotenoid, Thrombolytic.
INTRODUCTION: Prevalence of diseases today associated to lifestyle is known to be closely associated to oxidative stress.
Oxidative stress is defined as “a state in which oxidation exceeds the antioxidant system in the body secondary to a loss of the balance between them causing cell damage by an over abundance of oxidants like the ROS (Reactive Oxygen Species like for e.g. oxygen ions, free radicals and peroxide)”.
Lutein (β, ε- carotene- 3, 3’ –diol), a xanthophyll pigment is one of the many carotenoids found naturally occurring in plants such as green leafy vegetables (spinach, kale), corn, egg yolk and animal fats 1. Presence of this isomer of zeaxanthin in human tissues is of dietary origin. Cooking food containing lutein/zeaxanthin may increase the bioavailability by disrupting the cellular matrix and the carotenoid protein complexes 2. Lutein and zeaxanthin are the only carotenoids found both in macula and lens of the human eye (zeaxanthin predominating in the macula lutea, lutein is present elsewhere in the retina) and have dual function in both tissues to act as powerful antioxidants 3, 4 and filters high energy blue light 5, 6 to protect the eyes from oxidative stress caused by cigarette smoke and sunlight which can lead to age related macular degeneration and cataracts. Non-dietary factors affecting absorption of lutein and zeaxanthin include age, body composition, gender, malabsorption of fats, alcohol consumption, smoking and liver or kidney disease7-10.
The study was conducted to assess the antioxidant potential of lutein in different solvents and also to evaluate its antihemolytic and thrombolytic activity.
MATERIALS AND METHODS:
Lutein 90% was purchased from Haihang Industry, Jinan city, China; Gallic acid from Sigma Co.; all the other chemicals required for antioxidant studies were purchased from Himedia. Human blood was withdrawn for the antihemolytic and thrombolytic potential studies only after incurring the institutional ethical clearance [Ref: NU/CEC/BRNS (Pro.)-01/2014] and consent from the individual.
In-vitro antioxidant studies of lutein:
The invitro antioxidant potential of lutein was assessed by dissolving in various solvents like chloroform, ethanol, methanol and dimethyl sulfoxide (DMSO), using suitable methods. The solvents were selected since the solubility of lutein in these solvents is known11. The experiments were performed in triplicates.
Total Antioxidant Assay:
The estimation of total antioxidants was done by the method of 12. The formation of blue- green phosphomolybdenum complex was measured at 695nm. The total antioxidant capacity was expressed in terms of gallic acid equivalents.
ABTS Assay:
The method of 13 was followed with slight modification. In brief, the working solution was prepared by mixing the two stock solutions (7.4mM ABTS and 2.6mM Potassium persulfate). The working solution was further diluted with ethanol to which the sample dissolutions were added. Then the absorbance was taken at 734nm using the spectrophotometer. The result was expressed as percent of radical scavenging activity.
DPPH Assay:
The method of 14 was followed. The free radical scavenging activity of lutein when dissolved in various solvents were measured by the formation of stable 1, 1- diphenyl-2-picryl hydrazyl (DPPH) radical using a spectrophotometer at 517nm. The percentage of radical scavenging activity was calculated.
FRAP-TPTZ Assay:
The method of 15 was used. The Ferric Reducing Antioxidant Power was determined using 2, 4, 6- tripyridyl–S-triazine (TPTZ) in a spectrophotometer at 595nm. The ferric ion reducing potential was expressed in terms of gallic acid equivalents.
Superoxide Radical Scavenging Assay:
The method of 16 was used. The superoxide radical generated by the photo-oxidation of methionine-riboflavin and their scavenging property was determined spectrophotometrically at 560nm using nitroblue tetrazolium (NBT) as the chromogenic substrate. The percentage of superoxide radical scavenged was calculated.
Peroxide Radical Scaveging Assay:
The method of 17 was followed. The hydrogen peroxide radical formed was measured spectrophotometrically at 240nm. The result was expressed as percentage of peroxide radical scavenging activity.
Hydroxyl Radical Scavenging Assay:
The method of 18 was followed. The hydroxyl radical scavenged was measured spectrophotometrically at 532nm. The result was expressed as percentage of hydroxyl radical scavenging activity.
In vitro Erythrocyte Membrane Stabilization and Thrombolytic Potential:
Heat induced Hemolysis assay:
The method of 19 was followed. The red blood cell suspension was pre-incubated with lutein dissolved in different solvents for 20minutes at 55°C in the water bath. A control was maintained for each solvent. Then the absorbance of the suspension was measured at 540nm. Aspirin was used as positive control.
Osmotic Fragility of Erythrocytes:
The method of 16 was followed. The erythrocyte suspension along with lutein solution was added to 0.88%, 0.60%, 0.52% and 0.44% saline and distilled water. The absorbance of the suspension was measured at 540nm. The absorbance at 0.44% was taken against the absorbance with erythrocyte suspension in distilled water as control.
Thrombolytic Potential:
The thrombolytic potential was evaluated by the method of 20. Lutein was incubated with the pre-weighed clot for 90 minutes at 37°C. The clots were centrifuged, the supernatant was discarded and clot was weighed again. The percentage of clot dissolved was calculated.
RESULTS:
Table 1 shows the results for the antioxidant study of lutein. Lutein in ethanol and methanol showed a comparatively better activity than when dissolved in other solvents for ABTS radical scavenging activity. Whereas, DPPH activity and hydroxyl radical scavenging activity was comparatively better when dissolved in chloroform. Lutein when dissolved in methanol showed a moderate activity in scavenging radicals such as superoxide and hydrogen peroxide. Total antioxidant capacity and FRAP potential were tabulated in terms of µg equivalents of gallic acid (GA) and a moderate antioxidant potential was seen when lutein was dissolved in chloroform. However, the antioxidant potential in comparison to that of gallic acid was not highly significant.
TABLE 1: SHOWING THE RESULTS OF ANTIOXIDANT STUDY
Sl. No. | Standard Gallic Acid(1mg/ml) | Lutein in Ethanol (1mg/ml) | Lutein in Methanol (1mg/ml) | Lutein in Chloroform (1mg/ml) | Lutein in DMSO (1mg/ml) |
ABTS Radical Scavenging Assay | 48.33% | 29.4% | 29.4% | 27.7% | 0 |
DPPH Radical Scavenging Assay | 96.8% | 16.7% | 17.4% | 42.1% | 18.1% |
Superoxide Radical Scavenging Assay | 79.2% | 0 | 39.8% | 0 | 7.0% |
Hydrogen Peroxide Radical Scavenging Assay | 16.9% | 1.2% | 4.6% | 0.4% | 1.5% |
Total Antioxidant Capacity | µg equivalents of GA | 31.5 | 17.1 | 38.0 | 37.5 |
ferric Anion Reducing Potential | µg equivalents of GA | 46.0 | 29.0 | 7.7 | 60.3 |
Hydroxyl Radical Scavenging Assay | 32.6% | 14.2% | 0 | 17.6% | 10.5% |
It was observed that lutein when dissolved in chloroform has shown to reduce heat induced hemolysis (Fig. 1); though no significant difference was observed in hemolysis induced by hypotonic solution when compared to aspirin (Fig. 2). The thrombolytic activity of lutein dissolved in ethanol was mild when compared to that of trypsin where as the lutein when dissolved in methanol and DMSO did not exhibit any thrombolytic property (Fig. 3).
DISCUSSION: Reactive oxygen species (ROS) generated in tissues and cells have damaging effects on nucleic acids (mainly DNA), proteins, carbohydrates and lipids. The generation of ROS is initiated by several factors like chemicals, radiation, etc. The antioxidants that eliminate the pro-oxidants and scavenge free radicals controls the deleterious reactions and their effects. Carotenoids independent of their provitamin-A activity have reported biological effects as antioxidants. The present study showed that lutein (90% purity) has a effective antioxidant property; in that it scavenges the free radicals generated such as ABTS, DPPH, superoxide and hydroxyl radicals and it also exhibits total antioxidant potential and Ferric anion reducing potential when dissolved in different solvents like chloroform, ethanol, methanol and DMSO.
The solvents for the study were selected on the basis of the previous findings by 11. A cohort study by 21, 22; have shown individually that consumption of supplements with lutein and zeaxanthin together shows an elevated antioxidant status. A study by 23 has also shown in Electron Spin Resonance (ESR) and by chemical detection that lutein exhibits a greater efficiency than β-carotene in scavenging superoxide, hydroxyl radicals but not in quenching the singlet oxygen in which β-carotene exhibits a promising activity. In our study we found that lutein when dissolved in chloroform exhibited a potential antioxidant property. Ethanol and methanol dissolutions of lutein did not exhibit a promising activity, but lutein in DMSO showed a moderate activity for the assays performed. Previous in vitro antioxidant studies on lutein by 24, has shown that for 50% scavenging of free radicals like superoxide, hydroxyl and DPPH, the concentration of lutein required was 21μg/ml, 1.75μg/ml and 35μg/ml respectively, whereas in the present study lutein was required at a much higher concentration to show similar effect.
Thrombolysis refers to the breakdown of blood clots by the tissue plasminogen activators which clear the fibrin cross-linking. These thrombolytic agents are normally protein in nature which mimics the action of tissue plasminogen activators. The ability of lutein to dissolve the blood clot was studied and no significant difference was seen from the treated and control group indicating a poor thrombolytic potential.
Hemolysis of the erythrocytes may be seen due to disruption of its membrane by numerous external factors like heat, tonicity and solute concentration. The anti-hemolytic studies reveal the ability of any substance to stabilize the membrane and reduce the extent of lysis of red blood cells. The osmotic lysis of red blood cells is seen due to entry of water into the cell. As membranes are composed of polyunsaturated fatty acids, elevated temperature increases fluidity of the membrane leading to rupture of the lipid bilayer. The target drug can prevent the entry of water into the cell and prevent the cell rupture or it can stabilize the fluidity of the membrane and prevent the lysis. There are few references in the literature about anti-hemolytic potential of lutein. The present study indicated a potent anti-hemolytic effect against heat induced hemolysis. The possible explanation for this observation is its chemical nature. As it is a complex lipid molecule, when mixed with the erythrocyte suspension, probably increased the fluidity of the membrane and a much higher temperature was required to disrupt the membrane integrity.
CONCLUSION: The major conclusion from this study is that lutein has remarkable membrane stabilizing property against heat induced lysis of the erythrocytes. The other conclusions are lutein has moderate antioxidant and a poor thrombolytic potential. Further this study can be extended to confirm the findings and derive the exact mechanism of its anti-hemolytic effect.
ACKNOWLEDGEMENT: The authors would like to thank Board of Research in Nuclear Sciences (BRNS), Department of Atomic Energy (DAE) for providing the necessary funding for the project (Sanction No.: 2013/34/3/BRNS). Also the authors thank all the research scholars and Central Research Laboratory, K S Hegde Medical Academy, Nitte University for their kind support.
CONFLICT OF INTEREST: The authors declare no conflict of interest.
REFERENCES:
- El-Sayed M. Abdel-Aal, Humayoun Akhtar, Khalid Zaheer and Rashida Ali: Dietary Sources of Lutein and Zeaxanthin Carotenoids and Their Role in Eye Health. Nutrients 2013; 5(4): 1169-1185.
- Forman MR, Borkowf CB, Cantwell MM, Steck S, Schatzkin A, Albert PS and Lanza E: Components of variation in serum carotenoid concentrations: the Polyp Prevention Trial. European Journal of Clinical Nutrition 2009; 63: 763–770.
- Ana Zulueta, Maria J. Esteve, Ana Frígola, ORAC and TEAC assays comparison to measure the antioxidant capacity of food products. Food Chemistry 2009; 114, (1): 310-316.
- İlhami Gülçin: Antioxidant activity of food constituents: an overview. Archives of Toxicology 2012; 86 (3): 345-391.
- John Paul San Giovanni and Martha Neuringe: The putative role of lutein and zeaxanthin as protective agents against age-related macular degeneration: promise of molecular genetics for guiding mechanistic and translational research in the field. Am J Clin Nutr 2012; 96: 1223S–33S.
- Wilhelm Stahl and Helmut Sies: b-Carotene and other carotenoids in protection from sunlight. Am J Clin Nutr 2012; 96:1179S–84S
- Albanes D, Virtamo J, Taylor PR, Rautalahti M, Pietinen P, Heinonen OP: Effects of supplemental beta-carotene, cigarette smoking, and alcohol consumption on serum carotenoids in the Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study. Am J Clin Nutr 1997; 66: 336-372.
- Alberg A: The influence of cigarette smoking on circulating concentrations of antioxidant micronutrients. Toxicology 2002; 180:121-137.
- Brady WE, Mares-Perlman JA, Bowen P, Stacewicz-Sapuntzakis M: Human serum carotenoid concentrations are related to physiologic and lifestyle factors. J Nutr 1996; 126: 129-137.
- Lo Scalzo R: Measurement of free radical scavenging activity of gallic acid and unusual antioxidants as sugars and hydroxyacids. Electronic Journal of Environmental, Agricultural and Food Chemistry 2010; 9(8): 1360–1371.
- Neal Craft E: Relative solubility, stability, and absorptivity of lutein and β-Carotene in organic solvents. J Agric Food Chem 1992; 40: 431-434.
- Prieto P, Pineda M, Agulilar M: Spectrophotometric quantitation of antioxidant capacity through the formation of a phosphomolybdenum complex: Specific application to the determination of vitamin E. Anal Biochem 1999; 269: 337-341.
- Arnao MB, Cano A, Acosta M: The hydrophilic and lipophilic contribution to total antioxidant activity. Food Chemistry 2001; 73: 239–244.
- Braca A, Tommasi ND, Bari LD, Pizza C, Politi M, Morelli I: Antioxidant principles from Bauhinia terapotensis. Journal of Natural Products 2001; 64: 892–895.
- Benzie IFF, Strain JJ: Ferric reducing ability of plasma (FRAP) as a measure of antioxidant power: The FRAP assay. Anal Biochem 1996; 239: 70-76.
- Suchetha Kumari N, Yogish Somayaji T, Tejashvi R, Damodara Gowda KM, Chandrika Rao: Antioxidant, erythrocyte membrane stability and thrombolytic potential of diallyl disulphide. Int. J Pharma Sci Res 2014; 6(5): 6474-6480.
- Ruch RT, Cheng SJ, Klaunig JE: Spin trapping of superoxide and hydroxyl radicals. J methods in enzymology 1984; 105: 198-209
- Elizabeth K, Rao MWA: Oxygen radical scavenging activity of Curcumin. Int J Pharmaceu 1990; 58: 237‐
- Priyanga Ranasinghe, Pathmasiri Ranasinghe, Kaushalya WP, Abeysekera M, Sirimal Premakumara GA, Yashasvi Perera S: et al. In vitro erythrocyte membrane stabilization properties of Carica papaya leaf extracts. Phcog Res 2012; 4(4): 196-202.
- Prasad, S, Kashyap SR, Deopujari JY, Purohit HJ, Taori GM, Daginawala HF: Effect of Fagonia arabica (Dhamasa) on in vitro thrombolysis. BMC Complement Altern Med 2007; 7(36): 1-6.
- Laura Voorrips E, Alexandra Goldbohm R, Henny Brants AM, Geert van Poppel AFC, Ferd Sturamns, Rudolph Hermus JJ, et al.: A prospective study on antioxidant and folate intake and male lung cancer risk. Cancer Epidemiology, Biomarkers and Prevention 2000; 9: 357-365.
- Ryan Graydon, Ruth Hogg E, Usha Chakravarthy, Ian Young S, Jayne Woodside V: The effect of lutein and zeaxanthin rich foods v. supplements on macular pigment level and serological markers of endothelial activation, inflammation and oxidation: pilot studies in healthy volunteers. British Journal of Nutrition 2012; 108: 334-342.
- Chang-Lian Peng, Zhi-Fang Lin, Yue-Zeng Su, Gui-Zhu Lin, Hong– Yan Dou, and Cheng-Xue Zhao: The antioxidative function of lutein: electron spin resonance studies and chemical detection. Functional Plant Biology 2006; 33: 839-846.
- Edakkadath Sindhu R, Korenganath Preethi C, Ramadasan Kuttan: Antioxidant activity of carotenoid lutein in vitro and in vivo. Indian Journal of Experimental Biology 2010; 48: 843-848.
How to cite this article:
Vidya V, Somayaji TY, Pooja S, Patil S, Fernandes R and Krishna AP: Assessment of Membrane Stabilization, Antioxidant and Thrombolytic Potential of Lutein- An In-Vitro Study. Int J Pharm Sci Res 2015; 6(10): 4478-83.doi: 10.13040/IJPSR.0975-8232.6(10).4478-83.
All © 2013 are reserved by International Journal of Pharmaceutical Sciences and Research. This Journal licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 3.0 Unported License.
Article Information
45
4478-83
537
1233
English
Ijpsr
V. Vidya , Yogish Somayaji T. , S. Pooja , Shrikant Patil, Ronald Fernandes and A. P. Krishna
Central Research Laboratory , KS Hegde Medical Academy, Nitte University, Karnataka, India
apsnkrishna@yahoo.com
13 April, 2015
06 June, 2015
29 July, 2015
10.13040/IJPSR.0975-8232.6(10).4478-83
01 October, 2015